t-N-甲基-d-酸盐受体:为d-Serine被认为是它的反向协同激动剂提供了理由
Stephen Beesley1, Sanjay S Kumar1
1Department of Biomedical Sciences, College of Medicine & Program in Neuroscience Florida State University, 1115 W. Call Street, Tallahassee, FL, 32306-4300, USA.
Neuropharmacology
|July 12, 2023
概括
N-甲基-d-酸盐受体 (NMDARs) 对学习和记忆至关重要. 本综述探讨了它们在叶 (TLE) 中的作用,以及d-serine作为治疗剂的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- N-甲基-d-酸盐受体 (NMDARs) 对学习和记忆至关重要,但它们的全部功能尚不清楚.
- 需要进行研究来了解NMDAR的生物物理特性,子单元组成以及中枢神经系统健康和疾病中的作用.
- (TLE) 是一种常见的神经退行性疾病,与NMDAR功能障碍有关.
研究的目的:
- 综合关于NMDARs的新信息,重点关注突触可塑性.
- 为了研究NMDARs和d-serine在神经退行性疾病发病过程中的关系.
- 探索三异体NMDARs (t-NMDARs) 的结构功能和d-素作为反向协激剂的作用.
主要方法:
- 审查关于NMDARs,突触可塑性和TLE的现有文献.
- 关于d-serine的谷氨酸受体生物学和质生物学之间的相互作用的分析.
- 探索神经炎症在神经退行和TLE中的作用.
主要成果:
- d-氨酸会影响NMDAR功能和TLE的发生.
- 三异体NMDARs (t-NMDARs) 的结构-功能关系是理解d-氨酸的逆共激素作用的关键.
- 神经炎症和神经退行在TLE中相互联系.
结论:
- 内源的d-氨酸在大脑功能中起着重要作用.
- 了解d-serine的起源和质生物学,为TLE提供了新的视角.
- 对于TLE治疗,特别是对药物耐药的病例,d-氨酸具有治疗潜力.
相关概念视频
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K
Cholinergic Receptors: Nicotinic
2.9K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Drug-Receptor Interaction: Agonist
2.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.6K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K


